BARBIERI, MARZIA
BARBIERI, MARZIA
Dipartimento di Scienze Cliniche e di Comunità
Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features
2023 B. Fattizzo, F. Serpenti, F. Versino, G. Cassanello, L.M. Cro, M. Barbieri, G.A. Croci, N. Revelli, M.G. Della Porta, W. Barcellini
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade
2022 L. Elli, P. Soru, L. Roncoroni, F.G. Rossi, V. Ferla, L. Baldini, N. Nandi, L. Scaramella, A. Scricciolo, A. Rimondi, N. Fusco, G.A. Croci, U. Gianelli, L. Cro, M. Barbieri, V. Lombardo, A. Costantino, V. Vaira, S. Ferrero, G.E. Tontini, G. Barigelletti, S. Fabiano, L. Doneda, M. Vecchi
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
2022 B. Fattizzo, G.V. Levati, J.A. Giannotta, G. Cassanello, L.M. Cro, A. Zaninoni, M. Barbieri, G.A. Croci, N. Revelli, W. Barcellini
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients
2020 M. Lionetti, M. Barbieri, V. Favasuli, E. Taiana, S. Fabris, C. Favoino, G. Ciceri, S. Matis, M. Colombo, R. Massara, G. Reda, M. Gentile, V. Spina, D. Rossi, L. Baldini, G. Gaidano, F. Fais, M. Ferrarini, F. Morabito, G. Cutrona, A. Neri
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
2020 E. Taiana, V. Favasuli, D. Ronchetti, K. Todoerti, F. Pelizzoni, M. Manzoni, M. Barbieri, S. Fabris, I. Silvestris, M.E. Gallo Cantafio, N. Platonova, V. Zuccalà, L. Maltese, D. Soncini, S. Ruberti, M. Cea, R. Chiaramonte, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
2020 P. Monti, M. Lionetti, G. De Luca, P. Menichini, A.G. Recchia, S. Matis, M. Colombo, S. Fabris, A. Speciale, M. Barbieri, M. Gentile, S. Zupo, M. Dono, A. Ibatici, A. Neri, M. Ferrarini, F. Fais, G. Fronza, G. Cutrona, F. Morabito
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
2020 M. Colombo, S. Garavelli, M. Mazzola, N. Platonova, D. Giannandrea, R. Colella, L. Apicella, M. Lancellotti, E. Lesma, S. Ancona, M.T. Palano, M. Barbieri, E. Taiana, E. Lazzari, A. Basile, M. Turrini, A. Pistocchi, A. Neri, R. Chiaramonte
Jagged blockade promotes tumor cells response to Bortezomib in a zebrafish model of multiple myeloma
2019 M. Colombo, M. Mazzola, R. Colella, M.T. Palano, D. Giannandrea, M. Barbieri, N. Platonova, A. Neri, A.S. Pistocchi, R. Chiaramonte
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia
2019 G. Reda, R. Cassin, M. Gentile, F.R. Mauro, D. Giannarelli, B. Fattizzo, M. Barbieri, I. Silvestris, S. Fabris, F. Morabito, A. Neri, W. Barcellini, A. Cortelezzi
Notch signaling promotes drug resistance in multiple myeloma through the regulation of the CXCR4/SDF1α axis
2018 M. Colombo, N. Platonova, M. Mazzola, S. Garavelli, M. Barbieri, D. Giannandrea, M.T. Palano, E. Lazzari, A. Basile, A.S. Pistocchi, A. Neri, R. Chiaramonte
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model
2018 M. Colombo, M. Mazzola, R. Colella, S. Garavelli, M. Palano, M. Barbieri, E. Lazzari, D. Giannandrea, N. Platonova, A. Neri, A. Pistocchi, R. Chiaramonte
Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system
2018 M. Colombo, M. Mazzola, M. Barbieri, N. Platonova, M.T. Palano, S. Garavelli, D. Giannandrea, E. Lazzari, A. Basile, A.S. Pistocchi, A. Neri, R. Chiaramonte
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias
2018 B. Gerber, M. Manzoni, V. Spina, A. Bruscaggin, M. Lionetti, S. Fabris, M. Barbieri, G. Ciceri, A. Pompa, G. Forestieri, E. Lerch, P. Servida, F. Bertoni, E. Zucca, M. Ghielmini, A. Cortelezzi, F. Cavalli, G. Stussi, L. Baldini, D. Rossi, A. Neri
The Notch pathway drives the ability of the bone marrow niche to promote RNA editing in multiple myeloma
2017 M. Colombo, C. Raffaella, M. Barbieri, B. Francesco, E. Lazzari, K. Todoerti, C. Leslie, J.C. H. M., A. Neri, R. Chiaramonte
Primary plasma cell leukemia 2.0: advances in biology and clinical management
2016 A. Neri, K. Todoerti, M. Lionetti, V. Simeon, M. Barbieri, F. Nozza, G. Vona, A. Pompa, L. Baldini, P. Musto
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature
2016 M. Lionetti, M. Barbieri, M. Manzoni, S. Fabris, C. Bandini, K. Todoerti, F. Nozza, D. Rossi, P. Musto, L. Baldini, A. Neri
HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF DIS3 MUTATIONS IN MULTIPLE MYELOMA
2015 M. Barbieri
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia
2015 F. Maura, L. Mosca, S. Fabris, G. Cutrona, S. Matis, M. Lionetti, L. Agnelli, M. Barbieri, M. D'Anca, M. Manzoni, M. Colombo, C. Massucco, D. Reverberi, M. Gentile, A.G. Recchia, S. Bossio, F. Ilariucci, C. Musolino, F. Di Raimondo, A. Cortelezzi, F. Morabito, M. Ferrarini, A. Neri
Compendium of FAM46C gene mutations in plasma cell dyscrasias
2015 M. Barbieri, M. Manzoni, S. Fabris, G. Ciceri, K. Todoerti, V. Simeon, P. Musto, A. Cortelezzi, L. Baldini, A. Neri, M. Lionetti
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation
2015 M. Lionetti, M. Barbieri, K. Todoerti, L. Agnelli, S. Marzorati, S. Fabris, G. Ciceri, S. Galletti, G. Milesi, M. Manzoni, M. Mazzoni, A. Greco, G. Tonon, P. Musto, L. Baldini, A. Neri